PERSPECTIVE article

Front. Neurol.

Sec. Neurotrauma

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1587632

Gender and race in neurotrauma: Part 2-underrepresentation in clinical trial enrollment and impact on clinical outcomes

Provisionally accepted
  • 1Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
  • 2Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, United States
  • 3Department of Surgery, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
  • 4Neuroscience Program, Ottawa Hospital Research Institute, Ottawa, Canada

The final, formatted version of the article will be published soon.

The underrepresentation of women and racial minorities in clinical trials populations remains a persistent challenge across many medical specialties, including Neurosurgery. A diverse research cohort brings varied perspectives and experiences, which can lead to more innovative solutions to medical problems, generalizable findings, and the foundations to provide culturally competent care to the populations most affected by the condition at hand. The importance of representative Neurotrauma trial populations cannot be overstated, as results are essential to inform decision making and gender and race have both been shown to significantly influence patient outcomes, as seen in the traumatic brain injury and spinal cord injury populations. Although the path towards gender and racial parity in clinical trial participants has been slow, numerous actions have been taken, including the FDA Safety and Innovation Act (2012) and Omnibus Reform Act (2022). In this paper, we aimed to explore the barriers to and implications of inadequate representation in neurotrauma trials to outline a roadmap towards more diverse trial inclusion and retention. Key strategies include recruiting a diverse research team, developing flexible study protocols that support the varying needs of individuals of different backgrounds, establishing methods of data analysis that control for social and demographic factors instead of excluding individuals from participating, introducing patient navigators, reflecting on systemically engrained biases, implementing mandatory reporting of gender and race data, establishing and analyzing policies that keep researchers accountable towards goals of inclusive recruitment, and addressing unique barriers that individuals at the intersection of gender and racial minority status face.

Keywords: neurotrauma, gender, race, Intersectionality, trial representation

Received: 04 Mar 2025; Accepted: 28 Apr 2025.

Copyright: © 2025 Sue, Churchill, Parr and Tsai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Eve Tsai, Department of Surgery, Faculty of Medicine, University of Ottawa, Ottawa, K1H 8L6, Ontario, Canada

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.